Logo

American Heart Association

  8
  0


Final ID:

Discussant: ENDEAVOR

  • Lala, Anuradha  ( MOUNT SINAI HOSPITAL , New York , New York , United States )
  • Vest, Amanda  ( HRMC , Lake havasu city , Arizona , United States )
  • Author Disclosures:
    Anuradha Lala: DO have relevant financial relationships ; Research Funding (PI or named investigator):Astra Zeneca:Active (exists now) ; Executive Role:Journal of cardiac failure:Active (exists now) ; Speaker:Novartts:Past (completed) ; Speaker:zoll:Active (exists now) ; Research Funding (PI or named investigator):Merck:Active (exists now) ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now) ; Research Funding (PI or named investigator):cytokinetics:Active (exists now) ; Consultant:Boehringer Ingelheim:Past (completed) ; Research Funding (PI or named investigator):Bayer:Active (exists now) | Amanda Vest: DO have relevant financial relationships ; Research Funding (PI or named investigator):CareDx:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Building on the 4 Pillars: Novel Trials of Medical Therapy for Heart Failure

Monday, 11/18/2024 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
Discussant: REALIZE-K

Zannad Faiez, Allen Larry

Discussant: RSQ-777-02

Testani Jeffrey, Ommen Steve, Patel Ravi

More abstracts from these authors:
Novel Bumetanide Nasal Spray (BNS) Demonstrates Safety, Tolerability, and Equivalent Efficacy Compared to Intravenous and Oral Bumetanide

Kolski Brian, Bensimhon Daniel, Adler Eric, Kapur Navin, Lala Anuradha, Macaluso Gregory, Hajduczok Alexander, Neutel Joel

Panel Discussion

Tamirisa Kamala, Lala Anuradha, Mieres Jennifer, Volgman Annabelle, Sanghavi Monika, Mehta Laxmi, Bullock-palmer Renee

You have to be authorized to contact abstract author. Please, Login
Not Available